Selective Estrogen Receptor Modulators (SERMs) can be a cornerstone of pharmaceutical PCT interventions. They perform as aggressive inhibitors at estrogen receptors from the hypothalamus when exhibiting tissue-selective agonist or antagonist Homes all over the human body. SERMs are crucial in regulating post cycle estrogen manufacturing and mitigat